|Previous Section||Index||Home Page|
|Median waiting time (days)|
|Type of operation|
HES date 19992000
Dr. Evan Harris: To ask the Secretary of State for Health if he will list health authorities in England in order of the highest number of patients waiting for (a) an out-patient and (b) an in-patient appointment, indicating numbers of patients awaiting treatment, for (i) general surgery, (ii) urology, (iii) trauma and orthopaedics (iv) ear, nose and throat, (v) ophthalmology, (vi) oral surgery, (vii) cardiothoracic surgery, (viii) general medicine, (ix) cardiology, (x) thoracic medicine, (xi) infectious diseases, (xii) medical oncology, (xiii) geriatric medicine, (xiv) gynaecology and (xv) clinical oncology. 
Mr. Hutton: We do not collect information on total numbers of patients waiting for out-patient appointments. A table showing numbers of patients waiting more than 13 weeks for their appointments following general practitioner referral has been placed in the Library.
Under the NHS Plan, the national health service will reduce the maximum wait for an out-patient appointment from over six months today to three months by the end of 2005. By the same date the maximum wait for in-patient treatment will be reduced from 18 months today to six months.
1. Percentages rounded to the nearest whole figure
2. Comparable data are not yet available for 2000 and 2001
Health Survey for England: Trend data for adults 199399
20 Jul 2001 : Column: 731W
|Year (quarter)||(74)Number of diagnoses||Annual total|
(74) The numbers, particularly for the most recent quarters, will rise as further cases are reported
Confidential clinician and laboratory reporting to the Communicable Diseases Surveillance Centre the Public Health Laboratory Service
Ms Blears: We are committed to introducing a national textphone service for NHS Direct and expect this to be fully implemented within the next twelve months. An interactive e-mail inquiry service will be introduced in November this year.
20 Jul 2001 : Column: 732W
Yvette Cooper: For 200102, we have made available just over £84 million to Worcestershire county council for social services; this is 6.4 per cent. more than in 200001. Within this increase, Worcestershire's social services standard spending assessment has increased by 5.2 per cent.
Yvette Cooper: The number of delayed transfers of care in Worcestershire have been relatively steady, with no significant increases being reported. However, Worcestershire social services and the local health economy are working collaboratively to address existing needs, and several plans are currently in hand. These include:
expanded admission prevention and rapid response teams to prevent avoidable admission to hospital
ensuring effectiveness of Medical Assessment Units at hospitals to support early diagnosis and appropriate transfer to other services when acute admission is not required
further expansion of national health service rehabilitation services as part of our initiative on intermediate care
maximise the capacity of local community hospitals, develop residential re-ablement services in areas which currently do not receive this service, and continue expansion of home-based re-ablement services.
Mr. Alan Simpson: To ask the Secretary of State for Health when the Advisory Committee on Novel Foods and Processes discussed the Aventis study entitled "The Effect of Glufosinate-Resistant Corn on the Growth of Male Broiler Chickens"; and if he will place the minutes of this meeting in the Library. 
The study was part of the dossier submitted to the French competent authority in support of an application to market glufosinate tolerant maize. The study has recently been considered by the Advisory Committee on Animal Feedingstuffs who are currently finalising their comments.
Yvette Cooper: The main Government agency for research into the causes of and treatments for disease is the Medical Research Council (MRC), which receives its funding via the Department of Trade and Industry. The Department of Health funds research to support policy and the delivery of effective practice in the national health service.
20 Jul 2001 : Column: 733W
Between 1996 and 2001 the Department of Health and the MRC's estimated spend on research projects related to benign prostatic hyperplasia was over £1.5 million. In addition to these specific projects the Department of Health also provides funding for research commissioned by the research councils and charities that take place in the NHS. The total investment will therefore be considerably greater than the spend on individual projects. The National Research Register contains details of these projects and is available at: http://www.doh.gov.uk/ research/nrr.htm.
Dr. Richard Taylor: To ask the Secretary of State for Health if he will make a statement on performance related pay increases agreed for executive directors of the Worcestershire health authority in (a) 199899, (b) 19992000 and (c) 200001. 
Health authorities must publish details of pay awards to directors in their annual reports. These awards must be in line with national policy, and I understand that this has been the case for executive directors of Worcestershire health authority.
|Next Section||Index||Home Page|